Most recent by Paul J. DeMarco, MD, FACP, FACR, RhMSUS
Patients with gout 20% more likely to undergo lower extremity amputation
Patients with gout are 20% more likely to undergo lower extremity amputation versus those without gout, independent of comorbidities and other risk factors, according to data published in JAMA Network Open.
Nearly 30% of patients with lupus show low response to COVID-19 vaccine
About 29% of patients with systemic lupus erythematosus demonstrate low response to the COVID-19 vaccine, with immunosuppression therapy associated with decreased protection, according to data published in Arthritis & Rheumatology.
Pegloticase plus methotrexate bested pegloticase alone in uncontrolled gout response
An increased proportion of patients with uncontrolled gout maintained treatment response at 6 months with concomitant methotrexate and pegloticase, compared with pegloticase alone, according to data published in The Journal of Rheumatology.
Patients with rheumatic disease, COVID-19 more likely to require ventilation
Patients with rheumatic diseases plus COVID-19 are more likely to require mechanical ventilation, but demonstrated similar clinical features and hospitalization rates as those with COVID-19 only, according to data published in the Annals of the Rheumatic Diseases.
EULAR: Gout diagnosis should not depend on hyperuricemia alone
Physicians should refrain from diagnosing gout based solely on hyperuricemia, according to updated EULAR recommendations published in the Annals of the Rheumatic Diseases.